JASON KEITH ELY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GULFPORT, MS NPI 1104595396

General Payments — all program years on this page

$672.26

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $279.58 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $279.5821

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $141.0113
Novo Nordisk AS $49.013
Renalytix AI, Inc. $35.902
Indivior Inc. $22.591
Acerta Pharma LLC $15.941
Exact Sciences Corporation $15.131

By program year

Program yearAmountRecords
2021 $65.114
2022 $50.333
2023 $277.2416
2024 $279.5821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100262860 Novo Nordisk Inc $18.77 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100287064 Novo Nordisk Inc $16.59 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100351136 Novo Nordisk Inc $13.65 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104602796 AstraZeneca Pharmaceuticals LP $15.94 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070832 ABBVIE INC. $18.69 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070834 ABBVIE INC. $6.84 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070836 ABBVIE INC. $8.44 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070838 ABBVIE INC. $11.99 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070840 ABBVIE INC. $2.17 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070842 ABBVIE INC. $21.99 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070844 ABBVIE INC. $7.47 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070846 ABBVIE INC. $4.54 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070848 ABBVIE INC. $28.38 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070850 ABBVIE INC. $4.41 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070852 ABBVIE INC. $8.30 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070854 ABBVIE INC. $11.95 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070856 ABBVIE INC. $5.84 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114487325 Exact Sciences Corporation $15.13 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760618 Renalytix AI, Inc. $18.11 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760620 Renalytix AI, Inc. $17.79 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144551245 Indivior Inc. $22.59 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.